Cargando…

Identification and immune features of cuproptosis-related molecular clusters in polycystic ovary syndrome

Polycystic ovary syndrome (PCOS), a common reproductive endocrine disease, has clinically heterogeneous characteristics. Recently, cuproptosis causes several diseases by killing cells. Hence, we aimed to explore cuproptosis-related molecular clusters in PCOS and construct a prediction model. Based o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Zhe, Su, Wenjing, Li, Chenglong, Ding, Peihui, Wang, Yanlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849323/ https://www.ncbi.nlm.nih.gov/pubmed/36653385 http://dx.doi.org/10.1038/s41598-022-27326-0

Ejemplares similares

Identification of immune infiltration and cuproptosis-related molecular clusters in tuberculosis
por: Li, Sijun, et al.
Publicado: (2023)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Immune Dysfunction in Polycystic Ovary Syndrome
por: Banerjee, Soma, et al.
Publicado: (2023)

Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome
por: Na, Zhijing, et al.
Publicado: (2022)

Kisspeptin and Polycystic Ovary Syndrome
por: Tang, Rong, et al.
Publicado: (2019)

Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease
por: Lai, Yongxing, et al.
Publicado: (2022)

Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis
por: Pu, Yunfei, et al.
Publicado: (2023)

Molecular Research on Polycystic Ovary Syndrome (PCOS)
por: Daniele, Simona, et al.
Publicado: (2023)

Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics
por: Liu, Shuang, et al.
Publicado: (2023)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Molecular Features of Polycystic Ovary Syndrome Revealed by Transcriptome Analysis of Oocytes and Cumulus Cells
por: Li, Jie, et al.
Publicado: (2021)

Correction to: Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis
por: Pu, Yunfei, et al.
Publicado: (2023)

Identification of Cuproptosis Clusters and Integrative Analyses in Parkinson’s Disease
por: Zhang, Moxuan, et al.
Publicado: (2023)

Identification of immune cell infiltration and effective biomarkers of polycystic ovary syndrome by bioinformatics analysis
por: Gao, Mengge, et al.
Publicado: (2023)

Identification and immunological characterization of cuproptosis-related molecular clusters in idiopathic pulmonary fibrosis disease
por: Shi, Xuefeng, et al.
Publicado: (2023)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

On the Therapy for Polycystic Ovary Syndrome
por: Unfer, Vittorio, et al.
Publicado: (2017)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Update on polycystic ovary syndrome
por: Kim, Jin Ju
Publicado: (2021)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Computational characterization and identification of human polycystic ovary syndrome genes
por: Zhang, Xing-Zhong, et al.
Publicado: (2018)

The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents
por: Khashchenko, Elena, et al.
Publicado: (2020)

NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
por: Recuero, Amanda Medeiros, et al.
Publicado: (2022)

Bioinformatics analysis of the molecular mechanism of obesity in polycystic ovary syndrome
por: Zhou, Jiaojiao, et al.
Publicado: (2021)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Nanocomposites based on nanoceria regulate the immune microenvironment for the treatment of polycystic ovary syndrome
por: Yan, Sisi, et al.
Publicado: (2023)

Common clinical laboratory features among women with polycystic ovary syndrome and metabolic syndrome
por: Artyomenko, Volodymyr, et al.
Publicado: (2023)

Identification of subjects with polycystic ovary syndrome using electronic health records
por: Castro, Victor, et al.
Publicado: (2015)

Identification of the similarly expressed genes in patients with polycystic ovary syndrome and transsexuals
por: Dong, Rong, et al.
Publicado: (2021)

Reproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome
por: Crisosto, Nicolás, et al.
Publicado: (2017)

Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome
por: Falcetta, P., et al.
Publicado: (2021)

Consecutive Low Doses of Streptozotocin Induce Polycystic Ovary Syndrome Features in Mice
por: Ryu, Youngjae, et al.
Publicado: (2021)

Treatment options for polycystic ovary syndrome
por: Badawy, Ahmed, et al.
Publicado: (2011)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Complementary Therapy in Polycystic Ovary Syndrome
por: Aquino, C. I., et al.
Publicado: (2014)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_krrjcmis1lu3q1g2gkbr057gc8